Sana Biotechnology, Inc. (SANA)

NMS – Цена в реальном времени. Валюта: USD

3.42

+0.16 (4.91%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

3.42

0.00 (0.00%)

После закрытия: Jun 26, 2026, 7:59 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Sana Biotechnology, Inc. (SANA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. (SANA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sana Biotechnology to Present at June 2026 Investor Conferences

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

Видео

No Data

Пресс-релизы

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

Search stocks

Sana Biotechnology, Inc. (SANA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. (SANA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sana Biotechnology to Present at June 2026 Investor Conferences

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

Видео

No Data

Пресс-релизы

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates